Aframend Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Aframend General Information
Description
Developer of drug discovery technology designed to support pharmaceutical research and personalized medicine. The company develops technology that provides compound screening, molecular docking, molecular dynamics simulations, and personalized medicine capabilities, enabling researchers, healthcare providers, and students to accelerate drug discovery and treatment research.
Contact Information
Website
www.aframend.com.ngCorporate Office
- Ogbomoso
- Nigeria
Corporate Office
- Ogbomoso
- Nigeria
Aframend Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 20-May-2025 | Completed | Generating Revenue |
Aframend Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Qualcomm Make in Africa | Accelerator/Incubator | Minority |
Aframend FAQs
-
Where is Aframend headquartered?
Aframend is headquartered in Ogbomoso, Nigeria.
-
What industry is Aframend in?
Aframend’s primary industry is Discovery Tools (Healthcare).
-
Is Aframend a private or public company?
Aframend is a Private company.
-
What is Aframend’s current revenue?
The current revenue for Aframend is .
-
Who are Aframend’s investors?
Qualcomm Make in Africa has invested in Aframend.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process